Clinical Trial Update: Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update describing stem cell transplantation for participants with germline RUNX1-associated blood cancers; the trial is currently NOT_YET…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Leukemia
• Lymphoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Core Binding Factor Alpha Subunits, Hematologic Neoplasms | Phase 2 | Status: NOT_YET_RECRUITING